Creative Biolabs-Immuno-oncology

Anti-EGLN1 (clone EGLN1G) SynExpress T7-mSc-cJ-H Modified CD8+ T cells (CAT#: ITS-1224-CR2584)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target EGLN1 (clone EGLN1G). We employs the HBV (T7-mScarlet-c-Jun-HindIII) vector components and the SynExpress system of the Introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
EGLN1
Clone
EGLN1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mScarlet
Promoter
T7
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.98
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.